Exact Mass: 592.3836

Exact Mass Matches: 592.3836

Found 50 metabolites which its exact mass value is equals to given mass value 592.3836, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Santiaguine

(-)-Santiaguine

C38H48N4O2 (592.3777)


   

Avenestergenin B2

2-formyl-5,10-dihydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-14-oxo-tetradecahydro-1H-picen-3-yl benzoate

C37H52O6 (592.3764)


Avenestergenin B2 is found in cereals and cereal products. Aglycone from oat root. Aglycone from oat root. Avenestergenin B2 is found in cereals and cereal products.

   

3-(4-Hydroxybenzoyl)-1,3-Dihydroxy-14-taraxeren-28-oic acid

3-(4-Hydroxybenzoyl)-1,3-Dihydroxy-14-taraxeren-28-oic acid

C37H52O6 (592.3764)


   

7beta-(4-hydroxybenzoyloxy)-betulinic acid

7beta-(4-hydroxybenzoyloxy)-betulinic acid

C37H52O6 (592.3764)


   
   
   

15alpha-benzoyloxy-3beta,11alpha,12-trihydroxyurs-12-en-24-al

15alpha-benzoyloxy-3beta,11alpha,12-trihydroxyurs-12-en-24-al

C37H52O6 (592.3764)


   

3beta-acetoxy-27-(p-hydroxyl)benzoyloxylup-20(29)-en-28-oic acid

3beta-acetoxy-27-(p-hydroxyl)benzoyloxylup-20(29)-en-28-oic acid

C37H52O6 (592.3764)


   

triacetyl-disidein

triacetyl-disidein

C37H52O6 (592.3764)


   

Gallinamide A

Gallinamide A

C31H52N4O7 (592.3836)


D000890 - Anti-Infective Agents > D023181 - Antimicrobial Cationic Peptides

   

Avenestergenin B2

2-formyl-5,10-dihydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-14-oxo-docosahydropicen-3-yl benzoate

C37H52O6 (592.3764)


   

1-Hydroxy-3-((4-hydroxybenzoyl)oxy)-D-friedoolean-14-en-28-oic acid (1beta,3beta)-

1-Hydroxy-3-((4-hydroxybenzoyl)oxy)-D-friedoolean-14-en-28-oic acid (1beta,3beta)-

C37H52O6 (592.3764)


   

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (13Z,16Z)-tetracosa-13,16-dienoate

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (13Z,16Z)-tetracosa-13,16-dienoate

C30H57O9P (592.374)


   

(-)-Santiaguine

(-)-Santiaguine

C38H48N4O2 (592.3777)


   

1beta-hydroxymaprounic acid 3-p-hydroxybenzoate

1beta-hydroxymaprounic acid 3-p-hydroxybenzoate

C37H52O6 (592.3764)


A pentacyclic triterpenoid that is the benzoate ester obtained by the condensation of the 3-hydroxy group of 1beta-hydroxymaprounic acid with p-hydroxybenzoic acid. Isolated from Maprounea africana, it exhibits inhibitory activity against HIV-1 reverse transcriptase.

   

PA O-20:0/7:2;O2

PA O-20:0/7:2;O2

C30H57O9P (592.374)


   

PA O-27:2;O2

PA O-27:2;O2

C30H57O9P (592.374)


   

PA P-18:0/9:1;O2

PA P-18:0/9:1;O2

C30H57O9P (592.374)


   

PA 18:0/9:1;O

PA 18:0/9:1;O

C30H57O9P (592.374)


   

PA 22:0/5:1;O

PA 22:0/5:1;O

C30H57O9P (592.374)


   
   
   

PG O-20:1/4:1

PG O-20:1/4:1

C30H57O9P (592.374)


   

PG O-20:2/4:0

PG O-20:2/4:0

C30H57O9P (592.374)


   

PG O-22:2/2:0

PG O-22:2/2:0

C30H57O9P (592.374)


   
   

PG P-20:0/4:1

PG P-20:0/4:1

C30H57O9P (592.374)


   

PG P-20:0/4:1 or PG O-20:1/4:1

PG P-20:0/4:1 or PG O-20:1/4:1

C30H57O9P (592.374)


   

PG P-20:1/4:0

PG P-20:1/4:0

C30H57O9P (592.374)


   

PG P-20:1/4:0 or PG O-20:2/4:0

PG P-20:1/4:0 or PG O-20:2/4:0

C30H57O9P (592.374)


   

PG P-22:1/2:0

PG P-22:1/2:0

C30H57O9P (592.374)


   

PG P-22:1/2:0 or PG O-22:2/2:0

PG P-22:1/2:0 or PG O-22:2/2:0

C30H57O9P (592.374)


   
   

PG P-24:1 or PG O-24:2

PG P-24:1 or PG O-24:2

C30H57O9P (592.374)


   

PEth 25:1;O

PEth 25:1;O

C30H57O9P (592.374)


   
   

LCL521

LCL521

C31H52N4O7 (592.3836)


LCL521 is an acid ceramidase (ACDase) inhibitor. LCL521 also inhibits the lysosomal acid sphingomyelinase (ASMase)[1].

   

2-{[2-(dimethylamino)-3-methylpentanoyl]oxy}-n-(1-{[5-(3-methoxy-2-methyl-5-oxo-2h-pyrrol-1-yl)-5-oxopent-3-en-2-yl]-c-hydroxycarbonimidoyl}-3-methylbutyl)-4-methylpentanimidic acid

2-{[2-(dimethylamino)-3-methylpentanoyl]oxy}-n-(1-{[5-(3-methoxy-2-methyl-5-oxo-2h-pyrrol-1-yl)-5-oxopent-3-en-2-yl]-c-hydroxycarbonimidoyl}-3-methylbutyl)-4-methylpentanimidic acid

C31H52N4O7 (592.3836)


   

2-[(3s,14s,15s)-5,13-dihydroxy-7,14-dimethyl-11-methylidene-2,8-dioxo-15-(pentadecan-2-yl)-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

2-[(3s,14s,15s)-5,13-dihydroxy-7,14-dimethyl-11-methylidene-2,8-dioxo-15-(pentadecan-2-yl)-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C31H52N4O7 (592.3836)


   

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10bs)-1,9-dihydroxy-7-(hydroxymethyl)-4',4',4b,7,10a-pentamethyl-1,3,4,4a,5,6,6a,8,9,10,10b,11-dodecahydrospiro[chrysene-2,1'-cyclopentan]-8-yl 3-(4-hydroxyphenyl)prop-2-enoate

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10bs)-1,9-dihydroxy-7-(hydroxymethyl)-4',4',4b,7,10a-pentamethyl-1,3,4,4a,5,6,6a,8,9,10,10b,11-dodecahydrospiro[chrysene-2,1'-cyclopentan]-8-yl 3-(4-hydroxyphenyl)prop-2-enoate

C37H52O6 (592.3764)


   

bis(eburnamine)

bis(eburnamine)

C38H48N4O2 (592.3777)


   

16-ethyl-9-{16-ethyl-7-hydroxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium-6-yl}-8-hydroxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium

16-ethyl-9-{16-ethyl-7-hydroxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium-6-yl}-8-hydroxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium

[C38H48N4O2]2+ (592.3777)


   

(2s)-2-{[(2s)-2-{[(2s,3s)-2-(dimethylamino)-3-methylpentanoyl]oxy}-1-hydroxy-4-methylpentylidene]amino}-n-[(2s,3e)-5-[(2s)-3-methoxy-2-methyl-5-oxo-2h-pyrrol-1-yl]-5-oxopent-3-en-2-yl]-4-methylpentanimidic acid

(2s)-2-{[(2s)-2-{[(2s,3s)-2-(dimethylamino)-3-methylpentanoyl]oxy}-1-hydroxy-4-methylpentylidene]amino}-n-[(2s,3e)-5-[(2s)-3-methoxy-2-methyl-5-oxo-2h-pyrrol-1-yl]-5-oxopent-3-en-2-yl]-4-methylpentanimidic acid

C31H52N4O7 (592.3836)


   

1-(2,4-diphenyl-3-{3-[(2r)-piperidin-2-yl]-5,6-dihydro-4h-pyridine-1-carbonyl}cyclobutanecarbonyl)-3-[(2r)-piperidin-2-yl]-5,6-dihydro-4h-pyridine

1-(2,4-diphenyl-3-{3-[(2r)-piperidin-2-yl]-5,6-dihydro-4h-pyridine-1-carbonyl}cyclobutanecarbonyl)-3-[(2r)-piperidin-2-yl]-5,6-dihydro-4h-pyridine

C38H48N4O2 (592.3777)


   

5-{[(3r,5r)-5-[(3,5-dihydroxydecanoyl)oxy]-3-hydroxydecanoyl]oxy}-3,9-dihydroxydecanoic acid

5-{[(3r,5r)-5-[(3,5-dihydroxydecanoyl)oxy]-3-hydroxydecanoyl]oxy}-3,9-dihydroxydecanoic acid

C30H56O11 (592.3822)


   

5-({5-[(3,5-dihydroxydecanoyl)oxy]-3-hydroxydecanoyl}oxy)-3,9-dihydroxydecanoic acid

5-({5-[(3,5-dihydroxydecanoyl)oxy]-3-hydroxydecanoyl}oxy)-3,9-dihydroxydecanoic acid

C30H56O11 (592.3822)


   

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10bs)-1,9-dihydroxy-7-(hydroxymethyl)-4',4',4b,7,10a-pentamethyl-1,3,4,4a,5,6,6a,8,9,10,10b,11-dodecahydrospiro[chrysene-2,1'-cyclopentan]-8-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10bs)-1,9-dihydroxy-7-(hydroxymethyl)-4',4',4b,7,10a-pentamethyl-1,3,4,4a,5,6,6a,8,9,10,10b,11-dodecahydrospiro[chrysene-2,1'-cyclopentan]-8-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C37H52O6 (592.3764)


   

2-[5,13-dihydroxy-7,14-dimethyl-11-methylidene-2,8-dioxo-15-(pentadecan-2-yl)-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

2-[5,13-dihydroxy-7,14-dimethyl-11-methylidene-2,8-dioxo-15-(pentadecan-2-yl)-1-oxa-4,7,12-triazacyclopentadeca-4,9,12-trien-3-yl]-2-hydroxyethanimidic acid

C31H52N4O7 (592.3836)


   

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10bs)-1,9-dihydroxy-7-(hydroxymethyl)-4',4',4b,7,10a-pentamethyl-1,3,4,4a,5,6,6a,8,9,10,10b,11-dodecahydrospiro[chrysene-2,1'-cyclopentan]-8-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

(1s,2r,4as,4br,6ar,7r,8r,9r,10ar,10bs)-1,9-dihydroxy-7-(hydroxymethyl)-4',4',4b,7,10a-pentamethyl-1,3,4,4a,5,6,6a,8,9,10,10b,11-dodecahydrospiro[chrysene-2,1'-cyclopentan]-8-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C37H52O6 (592.3764)